Taken from http://www.snac.com/res_zma_1.htm
13. A percentage of testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5a-reductase. An invitro study was conducted to determine the inhibition of 5a-reductase activity by zinc sulphate and azelaic acid. When added at concentrations of 3 or 9 mmol/l, zinc was a potent inhibitor of 5a-reductase activity. At a high concentration of 15 mmol/l, zinc completely inhibited 5a-reductase. The addition of vitamin B-6 potentiated the effect of zinc and resulted in a two-fold increase in the inhibition of 5a-reductase. A moderate concentration of 1.5 mmol/l of zinc in combination with 0.025% of vitamin B-6 inhibited the 5a-reductase activity by 90%. The zinc and vitamin B-6 combination may be effective at limiting DHT production and could represent a potential therapeutic agent in the treatment of androgen related pathology.
Stamatiadis D, et al. Inhibition of 5a-reductase activity in human skin by zinc and azelaic acid. Brit J of Derm, 1988, Vol. 119, pp. 627-632.
I also found this one to be interesting:
14. Androgen metabolism and aromatization, androgen and estrogen receptor binding and circulating levels of reproductive hormones were studied in zinc deficient rats. The zinc deficient group had significantly lower serum concentrations of testosterone (2.8 +/- .07 nmol/L) compared to the controls (8.7 +/- .07 nmol/L). This represents a remarkable 68% reduction in circulating testosterone levels. Scatchard analysis of the receptor binding data showed a significantly higher number of estrogen receptors in the zinc deficient group (36.6 +/- 3.4 fmol/mg protein) than in controls (23.3 +/- 2.4 fmol/mg protein) and a significantly lower number of androgen binding sites in rats fed the zinc deficient diet (6.7 +/- o.7 fmol/mg protein) than in controls (11.3 +/- 1.2 fmol/mg protein). To summarize, zinc deficiency caused a 41% reduction in the number of androgen binding sites and a 57% increase in the number of estrogen receptors. These findings indicate that zinc deficiency significantly reduces circulating testosterone concentrations and modifies sex hormone receptor levels.
Om AS, et al. Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors. J Nutr, 1996, Apr, 126:4,842-8.
13. A percentage of testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5a-reductase. An invitro study was conducted to determine the inhibition of 5a-reductase activity by zinc sulphate and azelaic acid. When added at concentrations of 3 or 9 mmol/l, zinc was a potent inhibitor of 5a-reductase activity. At a high concentration of 15 mmol/l, zinc completely inhibited 5a-reductase. The addition of vitamin B-6 potentiated the effect of zinc and resulted in a two-fold increase in the inhibition of 5a-reductase. A moderate concentration of 1.5 mmol/l of zinc in combination with 0.025% of vitamin B-6 inhibited the 5a-reductase activity by 90%. The zinc and vitamin B-6 combination may be effective at limiting DHT production and could represent a potential therapeutic agent in the treatment of androgen related pathology.
Stamatiadis D, et al. Inhibition of 5a-reductase activity in human skin by zinc and azelaic acid. Brit J of Derm, 1988, Vol. 119, pp. 627-632.
I also found this one to be interesting:
14. Androgen metabolism and aromatization, androgen and estrogen receptor binding and circulating levels of reproductive hormones were studied in zinc deficient rats. The zinc deficient group had significantly lower serum concentrations of testosterone (2.8 +/- .07 nmol/L) compared to the controls (8.7 +/- .07 nmol/L). This represents a remarkable 68% reduction in circulating testosterone levels. Scatchard analysis of the receptor binding data showed a significantly higher number of estrogen receptors in the zinc deficient group (36.6 +/- 3.4 fmol/mg protein) than in controls (23.3 +/- 2.4 fmol/mg protein) and a significantly lower number of androgen binding sites in rats fed the zinc deficient diet (6.7 +/- o.7 fmol/mg protein) than in controls (11.3 +/- 1.2 fmol/mg protein). To summarize, zinc deficiency caused a 41% reduction in the number of androgen binding sites and a 57% increase in the number of estrogen receptors. These findings indicate that zinc deficiency significantly reduces circulating testosterone concentrations and modifies sex hormone receptor levels.
Om AS, et al. Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors. J Nutr, 1996, Apr, 126:4,842-8.